82 related articles for article (PubMed ID: 8388160)
21. A comparison of two ELISA methods for the investigation of anti-cytomegalovirus IgG antibodies.
Gutiérrez J; Maroto MC
Microbios; 1997; 90(364-365):151-4. PubMed ID: 9418034
[TBL] [Abstract][Full Text] [Related]
22. [CMV screening with the latex agglutination test in blood donors. Comparison between EIA and latex agglutination].
Müller R; Milbradt H
Beitr Infusionsther; 1990; 26():43-5. PubMed ID: 1703892
[TBL] [Abstract][Full Text] [Related]
23. Microsphere-based antibody assays for human parvovirus B19V, CMV and T. gondii.
Wang Y; Hedman L; Perdomo MF; Elfaitouri A; Bölin-Wiener A; Kumar A; Lappalainen M; Söderlund-Venermo M; Blomberg J; Hedman K
BMC Infect Dis; 2016 Jan; 16():8. PubMed ID: 26746194
[TBL] [Abstract][Full Text] [Related]
24. Comparison of complement fixation and fluorescent immunoassay (FIAX) for measuring antibodies to cytomegalovirus and herpes simplex virus.
Friedman HM; Tustin NB; Hitchings MM; Plotkin SA
Am J Clin Pathol; 1981 Sep; 76(3):305-7. PubMed ID: 6269420
[TBL] [Abstract][Full Text] [Related]
25. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity.
Baccard-Longere M; Freymuth F; Cointe D; Seigneurin JM; Grangeot-Keros L
Clin Diagn Lab Immunol; 2001 Mar; 8(2):429-31. PubMed ID: 11238233
[TBL] [Abstract][Full Text] [Related]
26. Cytomegalovirus IgM antibody detection: comparison of five assays.
Kraat YJ; Stals FS; Landini MP; Bruggeman CA
New Microbiol; 1993 Oct; 16(4):297-307. PubMed ID: 8264420
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of the new Roche platform of serological and molecular cytomegalovirus-specific assays in the diagnosis and prognosis of congenital cytomegalovirus infection.
Chiereghin A; Pavia C; Gabrielli L; Piccirilli G; Squarzoni D; Turello G; Gibertoni D; Simonazzi G; Capretti MG; Lanari M; Lazzarotto T
J Virol Methods; 2017 Oct; 248():250-254. PubMed ID: 28801056
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the shell vial pre-CPE method using monoclonal antibodies for the diagnosis of human cytomegalovirus infection in the field of pediatrics.
Numazaki K; Nagata N; Chiba S
In Vivo; 1992; 6(5):513-5. PubMed ID: 1333832
[TBL] [Abstract][Full Text] [Related]
29. Serological markers as indicators for congenital cytomegalovirus infection.
Abo-Elwafa HA; Eldin SS; Sharaf AE; Abdelmonem AM
Egypt J Immunol; 2010; 17(2):1-10. PubMed ID: 23082482
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a commercial latex agglutination test for detecting antibodies to cytomegalovirus in organ donors and transplant recipients.
Gray JJ; Alvey B; Smith DJ; Wreghitt TG
J Virol Methods; 1987 May; 16(1-2):13-9. PubMed ID: 3038936
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of cytomegalovirus (CMV) antibody screening tests for blood donors.
Sererat MN; Schifano JV; Lau P; Beikert E; Bhumbra NA; Nankervis GA
Am J Clin Pathol; 1986 Oct; 86(4):523-6. PubMed ID: 3020963
[TBL] [Abstract][Full Text] [Related]
32. Detection of antibodies to cytomegalovirus by immunofluorescence and enzyme immunoassay.
Korcáková L; Kaslík J; Slízová I
Czech Med; 1990; 13(1):29-33. PubMed ID: 2161726
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus testing: antibody determinations and virus cultures with recommendations for use.
Schultz DA; Chandler S
J Clin Lab Anal; 1991; 5(1):69-73. PubMed ID: 1847971
[TBL] [Abstract][Full Text] [Related]
34. [Cytomegalovirus IgM amd IgG antibodies in the sera of patients with acute and chronic upper respiratory infections].
Cengiz AT; Ataoğlu H; Kiyan M; Kiliç H
Mikrobiyol Bul; 1990 Oct; 24(4):307-13. PubMed ID: 1962842
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence and serum profile of cytomegalovirus infection among patients with hematologic disorders in Bahia State, Brazil.
de Matos SB; Meyer R; Lima FW
J Med Virol; 2011 Feb; 83(2):298-304. PubMed ID: 21181926
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
[TBL] [Abstract][Full Text] [Related]
37. Primary cytomegalovirus infection in patients with Guillain-Barré syndrome.
Steininger C; Seiser A; Gueler N; Puchhammer-Stöckl E; Aberle SW; Stanek G; Popow-Kraupp T
J Neuroimmunol; 2007 Feb; 183(1-2):214-9. PubMed ID: 17184845
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard.
Genser B; Truschnig-Wilders M; Stünzner D; Landini MP; Halwachs-Baumann G
Clin Chem Lab Med; 2001 Jan; 39(1):62-70. PubMed ID: 11256803
[TBL] [Abstract][Full Text] [Related]
39. Detection of cytomegalovirus antibody in stored blood products using latex agglutination.
Klinedinst AF; Baldwin ML; Ness PM
Transfusion; 1988; 28(6):563-5. PubMed ID: 2848338
[TBL] [Abstract][Full Text] [Related]
40. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
